Phase II and III CRO Services

Keeping Your Clinical Trials on Target Helps You to Create a Healthier World.

Navigating the complexities of Phases II and III of your clinical trial can be challenging. Having a partner that knows how to keep everything on track, on time and on budget is vital to the success of your study. Our proven expertise and highly personalized services provide the solutions you need to meet multiple milestones, solve recruitment challenges, monitor safety and effectiveness and so much more.

Backed by 25 years of experience, we deliver global service offerings that support your study from initial protocol development and feasibility all the way through final submission and post marketing. Because our range of full-service offerings is completely customizable, you receive a strategy designed specifically to fit your clinical trial.

This focus on scalability and efficiency combined with our proven expertise streamlines your Phase II and III clinical trial execution and positions you for success.

Process-Step-3

Expertise That Expands for Global Reach

Part of our customized approach to clinical trial strategy includes a global presence with experts in more than 60 countries who are trained and ready to support your Phase II or III study. This trusted network of investigators, study personnel and high-performing sites works together to provide you with accurate and optimized execution that streamlines day-to-day clinical trial work.

We also make sure our experts have access to the best tools and resources available. This not only empowers our personnel and sites to support your study strategy, it enables them to support your study participants. Supplying you with a seasoned team of global experts and providing them the support they need allows us to multiply value and maximize impact to ensure the success of your clinical trial.

Learn More

Customizable Services That Support Your Strategy

Our goal is to help you create a healthier world. By leveraging our demonstrated, global expertise, you have access to a wide range of full-service capabilities that will support and optimize your Phase II or III clinical trial strategy.

Our services include:

Therapeutic Centers Of Excellence That Add Value to Your Study

To meet the ever-changing needs of your Phase II or III study, we have built therapeutic Centers of Excellence (COEs) that enhance and underscore our capabilities and service offerings. These ecosystems of cross-functional teams create synergies and efficiencies that help your study reach its goals and milestones. Our COEs cover the following specialty research areas:

Oncology-Hematology Center of Excellence – Deep experience in a variety of solid tumors and hematologic cancers with strengths built to specifically optimize early phase studies.
Infectious Disease & Vaccines Center of Excellence – Our track record in this therapeutic area is a long one: We have supported the development of more than half of all antibiotics approved by FDA/EMA since 2010.
Rare Disease – A recognized leader in rare disease research: We’ve conducted more than 100 rare disease studies and bring unique solutions to their unique challenges.
General Medicine – Supporting an additional 13 therapeutic areas, with recent and relevant experience to support your next clinical trial.

Setting High Standards With Our Pattern of Excellence

Our goal of helping you to create a healthier world is more than just a promise or a tagline. It is a belief system that dictates the way we conduct our business and our day-to-day work. This is demonstrated in our Pattern of Excellence.

By holding ourselves accountable for your clinical trial, we make sure that your study – and the patients we hope to help – receive the highest quality service every day.

To learn more about our Pattern of Excellence, visit our Why Pharm-Olam page.

Why Pharm-Olam

Sponsor Testimonials

“Based on the performance of our study, we have selected Pharm-Olam to perform two additional studies.”

Pharma - Associate Director, Clinical Outsourcing

“Pharm-Olam also proved to be highly flexible, which is something I personally value and don’t always see at other CROs.”

Small Pharma - Director, Project Planning

Digital Compliance Conference